Development of oral vaccines to stimulate mucosal and systemic immunity: Barriers and novel strategies

Clinical Immunology and Immunopathology

Volumn 74, Issue 2, 1995, Pages 127-134

  Shalaby, W S W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028894461     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1995.1019     Document Type: Review

References (95)

1. Sabin, A. B., Oral poliovirus vaccine: History of its development and use and current challenge to eliminate poliomyelitis from the world. J. Infect. Dis. 151, 420-436, 1985.
2. Holmgren, J., Mucosal immunity and vaccination. FEMS Microbiol. Immunol. 89, 1-10, 1991.
3. Nicklin, S., and Miller, K., Local and systemic immune response to intestinally presented antigen. Int. Arch. Allergy Appi. Immunol. 72, 87-90, 1983.
4. Mattingly, J. A., and Waksman, B. H., Immunological suppression after oral administration of antigen. I. Specific suppressor cells formed in Peyer’s patches after oral administration of sheep erythrocytes and their systemic migration. J. Immunol. 121, 1878-1883, 1978.
5. Ngan, J., and Kind, L. S., Suppressor T cells for Ig E and Ig G in Peyer’s patches of mice made tolerant by the oral administration of ovalbumin. J. Immunol. 120, 861-865, 1978.
6. Brandtzaeg, P., Overview of the mucosal immune system. Curr. Top. Microbiol. Immunol. 146, 13-25, 1989.
7. McGhee, J., Mestecky, J., Dertzbaugh, M., Eldridge, J. H., Hirasawa, M., and Kiyono, H., The mucosal immune system from fundamental concepts to vaccine development. Vaccine 10, 75-88, 1992.
8. Neutra, M. R., Phillips, T., Mayer, E., and Fishkind, D. J., Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer’s patch. Cell Tissue Res. 247, 537-546, 1987.
9. Owen, R. L., Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer’s patches in the normal unobstructed mouse intestine: an ultrastructural study. Gastroenterology 72, 440-451, 1977.
10. Neutra, M. R., and Kraehenbuhl, J. P., M cell-mediated antigen transport and monoclonal Ig A antibodies for mucosal immune protection. Adv. Exp. Med. Biol. 327, 143-150, 1992.
11. Allan, C. H., Mendrick, D. L., and Trier, J., Rat intestinal M cells contain acidic endosomal-lysosomal compartments and express class II major histocompatibility complex determinants. Gastroenterology 104, 698-708, 1992.
12. Butcher, E., Rouse, R., Coffman, R., Nottenberg, C., Hardy, R., and Weismann, I., Surface phenotype of Peyer’s patches germinal center cells: Implications for the role of germinal center in B-cell differentiation. J. Immunol. 129, 2698-2707, 1982.
13. Butcher, E., The regulation of lymphocyte traffic, Curr. Top. Microbiol. Immunol. 128, 85-122, 1986.
14. Czerkinksy, C., Rüssel, M., Lycke, N., Lindblad, M., and Holmgren, J., Oral administration of streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary and extramucosal tissues. Infect. Immun. 57, 1072-1077, 1989.
15. Nedrud, J., Liang, X., Hague, N., and Lamm, M., Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 139, 3484-3492, 1987.
16. Czerkinksy, C., Svennerholm, A., Quiding, M., Jonson, R., and Holmgren, J., Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect. Immun. 59, 996-1001, 1991.
17. Lycke, N., and Holmgren, J., Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin. Infect. Immun. 57, 1137-1141, 1989.
18. Wells, H. G., and Osborne, J. B., The biological reactions of vegetable proteins. J. Infect. Dis. 8, 66-124, 1911.
19. Chase, M. W., Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 61, 257-259, 1946.
20. Mowat, A., The regulation of immune response to dietary protein antigens. Immunol. Today 8, 93-87, 1987.
21. Asherson, G., Zembala, M., Perera, M. A. C. C., Mayhew, B., and Thomas, W., Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer’s patches, mesenteric lymph nodes, and other lymphoid tissues. Cell Immunol. 33, 145-155, 1977.
22. Newby, T. J., Stokes, CR., and Bourne, F., Effects of feeding bacterial lipopolysaccharide and dextran sulphate on the development of oral tolerance to contact sensitizing agents. Immunology 41, 617-621, 1980.
23. Gautum, S. C., and Battisto, J. R., Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity. J. Immunol. 135, 2975-2983, 1985.
24. Kagnoff, M. F., Effects of antigen-feeding on intestinal systemic immune response. II. Suppression of delayed-type hypersensitivity reactions. J. Immunol. 120, 1509-1513, 1978.
25. Kagnoff, M. F., Effects of antigen-feeding on intestinal and systemic immune response. IV. Similarity between the suppressor factor in mice after erythrocyte-lysate injection and erythrocyte feeding. Gastroenterology 79, 54-61, 1980.
26. Kiyono, H., Mc Ghee, J. R., and Wannemuehler, M. J., Lack of tolerance in C3/He J mice. J. Exp. Med. 155, 605-610, 1982.
27. Rubin, D., Weiner, H. L., Fields, B. N., and Greene, M. I., Immunological tolerance after oral administration of reovirus: Requirement for two viral gene products for tolerance induction. J. Immunol. 127, 1697-1701, 1981.
28. + T lymphocytes. J. Immunol. 142, 748-752, 1989.
29. Nussenblatt, R., Caspi, R., Mahdi, R., Chan, C., Roberge, P., Lider, O., and Weiner, H., Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144, 1689-1695, 1990.
30. Khoury, S., Hancock, W., and Weiner, H., Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176, 1355-1364, 1992.
31. Friedman, A., and Weiner, H., Induction of anergy and/or active suppression in oral tolerance is determined by frequency of feeding and antigen dosage. J. Immunol. 150(8), 4A., 1993.
32. Mowat, A., Strobel, S., Drummond, H. E., and Ferguson, A., Immunological responses to fed protein antigens in mice. I. reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 45, 105-113, 1982.
33. Challacombe, S. J., and Tornasi, T. B., Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 152, 1459-1472, 1980.
34. Green, D. R., Mc Ghee, J., and Ptak, W., Contrasuppression and the control of microenvironmental immune response. Monogr. Allergy 24, 236-243, 1988.
35. Amerongen, H., Michetti, P., Weltzin, R., Lee, T., Kraehenbuhl, J., and Neutra, M., Transepithelial delivery of a recombinant HIV protein on hydroxyapatite for production of monoclonal anti-gp120 Ig A antibodies. J. Cell Biol. 115, 237a, 1991.
36. Owen, R., Pierce, N., Apple, R., and Cray, W., M cell transport of Vibrio chlolerae from the intestinal lumen into Peyer’s patches: A mechanism for antigen sampling and for microbial transepithelial migration. J. Infect. Dis. 153, 1108-1118, 1986.
37. Sicinski, P., Rowinski, J., Warchol, J. B., Jarzcebek, Z., Gut, W., Szczygiel, B., Bielecki, K., and Koch, G., Poliovirus type 1 enters the human host through intestinal M cells. Gastroenterology 98, 56-58, 1990.
38. Wolf, J. L., Rubin, D.H., Finberg, R., Kauffman, R., Sharpe, A. H., Trier, J. S., and Fields, B. N., Intestinal M cells: A pathway for entry of reovirus into the host. Science 212, 471-472, 1981.
39. Inman, L., and Cantey, J., Specific adherence of E. coli (strain RDEC-1) to membranous (M) cells of the Peyer’s patches in E. coli diarrhea in the rabbit. J. Clin. Invest. 71, 1-8, 1983.
40. Wassef, J. S., Keren, D. F., and Mailloux, J. L., Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis. Infect. Immun. 7, 858-863, 1989.
41. Kohbata, S., Yokoyama, H., and Yabuuchi, E., Cytopathogenic effect of salmonella typhi GIFU 10007 on M cells of murine ileal Peyer’s patches in ligated ileal loops: An ultrastructural study, Microbiol. Immunol. 30, 1225-1237, 1986.
42. Grutzkau, A., Hanski, C., Hahn, H., and Riecken, E., Involvement of M cells in the bacterial invasion of Peyer’s patches: A common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 31, 1011-1015, 1990.
43. Amerongen, H., Weltzin, R., Mack, J., Winner, L., Michetti, P., Apter, F., Kaehenbuhl, J., and Neutra, M., M-cell mediated antigen transport and monoclonal Ig A antibodies for mucosal immune protection. Ann. NY Acad. Sci. 664, 18-26, 1992.
44. Mojaverian, P., Ferguson, R., Vlasses, P., Rocci, M., Oren, A., Fix, J., Caldwell, L., and Gardner, C., Estimation of gastric residence time of the Heidelberg capsule in humans: Effect on varying food composition. Gastroenterology 89, 392-397, 1985.
45. Davis, S. S., Hardy, J., and Fara, J., Transit of pharmaceutical dosage forms through the small intestine. Gut 27, 886-892, 1986.
46. Pierce, N., and Cray, W., Determinants of the localization, magnitude, and duration of a specific mucosal Ig A plasma cell response in enterically immunized rats. J. Immunol. 128, 1311-1315, 1982.
47. Lange, S., Nygren, H., Svennerholm, A., and Holmgren, J., Antitoxic cholera immunity in mice: Influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of the intestine. Infect. Immunol. 28, 17-23, 1980.
48. Shalaby, W., and Park, K., Chemical modification of proteins and polysaccharides and its effect on enzyme-catalyzed degradation. In Biomedicai Polymers: Designed-To-Degrade Systems, pp. 213-258, Hanser Verlag, New York, 1994.
49. Shalaby, W., Blevins, W. E., and Park, K., In vitro and in vivo studies of enzyme-digestible hydrogels for oral drug delivery. J. Controlled Release 19, 131-144, 1992.
50. Shalaby, W., Blevins, W. E., and Park, K., The use of ultrasound imaging and fluoroscopic imaging to study gastric retention of enzyme-digestible hydrogels. Biomaterials 13(5), 289-296, 1992.
51. Cargill, R., Engle, K., Gardner, C., Porter, P., Sparer, R., and Fix, J., Controlled gastric emptying. II. In Vitro erosion and gastric residence times of an erodible device in beagle dogs. Pharm. Res. 6(6), 506-509, 1989.
52. Fix, J., Cargill, R., and Engle, K., Controlled gastric emptying. III. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm. Res. 10(7), 1087-1089, 1993.
53. Elson, C. O., Cholera toxin and its subunits as potential oral adjuvants. Curr. Top. Microbiol. Immunol. 146, 29-33, 1989.
54. Elson, C. O., Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132, 2736-2741, 1984.
55. Lehner, T., Bergmeier, L., Panagiotidi, C., Tao, L., Brookes, R., Klavinskis, L., Walker, P., Walker, J., Ward, R., Hussain, L., Gearing, A., and Adams, S., Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258(20), 1365-1369, 1992.
56. Lehner, T., Tao, L., Panagiotidi, C., Klavinskis, L., Brookes, R., Hussain, L., Meyers, N., Adams, S., Gearing, A., and Bergmeier, L., Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus. J. Virol. 68, 1624-1632, 1994.
57. Liang, X., Lamm, M. E., and Nedrud, J., Oral administration of cholera toxin-sendai virus conjugate potentiates gut and respiratory immunity against sendai virus. J. Immunol. 141, 1495-1501, 1988.
58. Doggett, T. A., and Curtiss, R., Delivery of antigens by recom binant avirulant salmonella strains. Adv. Exp. Med. Biol. 327, 165-173, 1992.
59. McGhee, J. R., and Mestecky, J., In defense of mucosal surfaces. development of novel vaccines for Ig A responses protective at the portals of entry of microbial pathogens. Inf. Dis. Clin. North Am, 4(2), 315-341, 1990.
60. Stover, C. K., de la Cruz, V., Bansal, G., Hanson, M., Fuerst, T., Jacobs, W., and Bloom, B., Use of recombinant BCG as a vaccine delivery vehicle. Adv. Exp. Med. Biol. 327, 175-182, 1992.
61. Stover, C., Bansal, G., Hanson, M., Burlein, J., Palaszynski, S., Young, J., Koenig, S., Young, D., Sadziene, A., and Barbour, A., Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (Osp A) lipoprotein: A candidate Lyme disease vaccine. J. Exp. Med. 178, 197-209, 1993.
62. Curtiss, R., Goldschmidt, R., and Pastian, R., In "Molecular Microbiology and Immunology of Streptococcus Mutans, p. 173, Elsevier, Amsterdam, 1986.
63. Mestecky, J., and Mc Ghee, J., Immunoglobulin A (Ig A): Molecular and cellular interactions involved in Ig A biosynthesis and immune response. Adv. Immunol. 40, 153-245, 1987.
64. Curtiss, R., Kelly, S., and Gulig, P., Selective delivery of antigens by recombinant bacteria. Curr. Top. Microbiol. Immunol. 146, 35-49, 1989.
65. Poirier, T., Kehoe, M., and Beachey, E., Protective immunity evoked by oral administration of attenuated aro A Salmonella typhimurium expressing cloned streptococcal M protein. J. Exp. Med. 168, 25-32, 1988.
66. Umesaki, Y., and Setoyama, H., Immune response of mice to orally administered asialo GMl-specific rabbit Ig G in the presence or absence of cholera toxin. Immunology 75, 386-388, 1992.
67. Lycke, N., and Holmgren, J., Strong adjuvant properties of cholera toxin on gut mucosal immune response to orally presented antigens. Immunology 59, 301-308, 1986.
68. Bromander, A., Holmgren, A., and Lycke, N., Cholera toxin stimulates 11-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146, 2908-2913, 1991.
69. Clements, J. D., Hartzog, N. M., Lyon, F. L., Adjuvant activity of E. coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 6, 269-277, 1988.
70. de Aizpurua, H. J., and Russell-Jones, G. J., Oral vaccination: Identification of classes of proteins that provoke an immune response upon oral feeding. J. Exp. Med. 167, 440-451, 1988.
71. Park, K., Shalaby, W. S. W., and Park, H., "Biodegradable Hydrogels for Drug Delivery," Technomics, Lancaster, PA., 1993.
72. Eldridge, J., Gilley, R., Staas, J., Moldoveanu, Z., Meulbroek, J., and Tice, T., Biodegradable microspheres: Vaccine delivery system for oral immunization. Curr. Top. Microbiol. Immunol. 146, 59-66, 1989.
73. Eldridge, J., Hammond, C., Meulbroek, J., Staas, J., Gilley, R., and Tice, T., Controlled vaccine release in the gutassociated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer’s patches. J. Controlled Release 11, 205-214, 1990.
74. O’Hagan, D., Palin, K., and Davis, S., Poly(butyl-2-cyanoacry-late) particles as adjuvants for oral immunization. Vaccine 7, 213-216, 1989.
75. O’Hagan, D., Palin, K., Davis, S., Artursson, P., and Sjoholm, I., Microparticles as potentially orally active immunological adjuvants. Vaccine 7, 421-424, 1989.
76. Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., Yamshchikov, G. V., Chen, D., and Eldridge, J. H., Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260, 1323-1327, 1993.
77. Bowersock, T. L., Shalaby, W. S. W., Levy, M., Samuels, M. L., Lallone, R., White, M. R., Borie, D., Lehmeyer, J., and Park, K., Evaluation of an orally administered vaccine, using hydrogels containing bacterial exotoxins of pasteurella haemolytica, in cattle, Am. J. Vet. Res. 55, 502-509, 1994.
78. Kwok, K. K., Groves, M. J., and Burgess, D. J., Production of 5-15 microns diameter alginate-polylysine microcapsules by an air-atomization technique. Pharm. Res. 8(3), 341-344, 1991.
79. Taggart, L. E., and Halbart, G. W., Assessment of polysaccha-ride gels as drug delivery vehicles. Int. J. Pharm. 100, 199-206, 1993.
80. Edman, P., Ekman, B., and Sjoholm, I., Immobilization of proteins in microspheres of biodegradable polyacryldextran. J. Pharm. Sci. 69(7), 838-842, 1980.
81. Artursson, P., Edman, P., Laakso, T., and Sjoholm, I., Characterization of polyacryl starch microparticles as carriers for proteins and drugs. J. Pharm. Sci. 73(11), 1507-1513, 1984.
82. Tabata, Y., and Ikada, Y., Synthesis of gelatin mirospheres containing interferon. Pharm. Res. 6(5), 422-427, 1989.
83. Lee, T. K., Sokoloski, T., and Royer, G. P., Serum albumin beads: An injectable biodegradable system for the sustained release of drugs. Science 213, 233-235, 1981.
84. Kawaguchi, H., Hoshino, F., and Ohtsuka, Y., Soapfree emulsion copolymerization of styrene with N-acryloylpyrrolidone and features of the resulting latices. Makromol. Chem. Rapid. Commun. 7, 109-114, 1986.
85. Shalaby, W. S. W., and Park, K., Biochemical and mechanical characterization of enzyme-digestible hydrogels. Pharm. Res. 7(8), 816-823, 1990.
86. Jayakrishnan, A., and Thanoo, B. C., Suspension polymerization of 2-hydroxyethylmethacryalte in the presence of polymeric diluents: A novel route to spherical highly porous beads for biomedical application. J. Biomed. Mat. Res. 24, 913-927, 1990.
87. Chʼng, H. S., Park, H., Kelly, P., and Robinson, J. R., Bioadhesive polymers as platforms for oral controlled drug delivery. II. Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J. Pharm. Sci. 74(4), 399-405, 1985.
88. Mathiowitz, E., Saltzman, W., Domb, A., Dor, Ph., and Langer, R., Polyanhydride microspheres as drug carriera. II. Microencap-sulation by solvent removal. J. Appi. Polym. Sci. 35(3), 755-774, 1988.
89. Chouinard, F., Buczkowski, S., and Laenaerts, V., Poly(alkylcy-anoacrylate) nanocapsules: Physicochemical characterization and mechanism of formation. Pharm. Res. 11(6), 869-874, 1994.
90. Michalek, S., Childers, N., Katz, J., Dertzbaugh, M., Zhang, S., Rüssel, M., Macrina, F., Jackson, S., and Mestecky, J., Liposomes and conjugative vaccines for antigen delivery and induction of mucosal immune responses. Adv. Exp. Med. Biol. 327, 191-197, 1992.
91. Kahn, M. Z., Opdeeck, J. P., and Tucker, I. G., Immunopotentiation and delivery systems for antigens for singlestep immunization: Recent trends and progress. Pharm. Res. 11(1), 2-11, 1994.
92. Zhang, Z. J., Davidson, L., Eisenbarth, G., and Weiner, H. L., Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Nail. Acad. Sci. USA 88, 10252-10256, 1991.
93. Higgins, P. J., and Weiner, W., Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol., 140, 440-445, 1988.
94. Weiner, H. L., Mackin, G. A., Matsui, M., Orav, E. J., Khoury, S., Dawson, D. M., and Hafler, D. A., Double blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259, 1321-1324, 1993.
95. Trentham, D. E., Dynesius-Trentham, R. A., Orav, E., Combitchi, D., Lorenzo, C., Sewell, K., Hafler, D. A., and Weiner, H. L., Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727-1730, 1993.